Solventum Names Parag Kachalia Global Clinical Evidence Director - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Solventum Names Parag Kachalia Global Clinical Evidence Director

New role will focus on clinical strategy supporting the company’s digital dental solutions.

  • By

  • News Staff

  • September 28, 2026

Share

  • 1

    Solventum appointed Parag Kachalia, DDS, as global clinical evidence director for its digital dental solutions.

  • 2

    Kachalia joined Solventum on September 15 and will focus on clinical evidence strategy.

  • 3

    He has 25 years of experience in clinical practice, academia, and dental technology strategy.

  • 4

    Kachalia previously served as head of clinical practice at Overjet and chief clinical officer of Seattle Study Club.

  • 5

    He was also a tenured faculty member at the University of the Pacific, Arthur A. Dugoni School of Dentistry.

Original Source(s)

Solventum Names Parag Kachalia Global Clinical Evidence Director

  • by News Staff

  • September 28, 2026

Related Content

Andau Medical Partners with IDS Spa to Bring BlancOne Click+ to U.S.

Ten-minute professional whitening system is designed for integration into routine hygiene appointments.

NIH Grant Supports Study of Piezoelectric Technology for Peri-Implantitis

The grant will support evaluation of Oral Biolife’s piezoelectric technology beyond its current development for periodontal bone regeneration.

Colgate Bright Smiles, Bright Futures®: Driving Behavior Change for the Next Billion Children and Their Families

Colgate-Palmolive builds on its legacy of oral health, publishing an impact evaluation, evolving its health education tools rooted in behavior change, and scaling its global health partnerships.